Article metrics

Original article
The safety of vedolizumab for ulcerative colitis and Crohn's disease

 

Online download statistics by month:

Online download statistics by month: February 2016 to March 2024

AbstractFullPdf
Feb 20166931001652
Mar 2016891774633
Apr 20163941192387
May 20165381157394
Jun 20162961287333
Jul 20162651322314
Aug 20162591343293
Sep 20162461469310
Oct 20162331536317
Nov 20163192129363
Dec 20162901190281
Jan 20174711502414
Feb 20171551027283
Mar 201732926306
Apr 2017441836470
May 2017301435397
Jun 20173261159268
Jul 201710431004295
Aug 201711071028242
Sep 20171082962268
Oct 201712321155287
Nov 201711171014303
Dec 2017758693232
Jan 2018953866309
Feb 2018887794277
Mar 2018962833236
Apr 2018894775202
May 2018842774185
Jun 2018709638186
Jul 2018907925190
Aug 2018983971219
Sep 2018903853216
Oct 2018946969215
Nov 20181024958352
Dec 2018882786336
Jan 201911951038404
Feb 2019932940411
Mar 2019916950423
Apr 2019879909348
May 20199941033478
Jun 2019941978430
Jul 2019768724431
Aug 2019784695442
Sep 2019691616477
Oct 2019766639424
Nov 2019744681402
Dec 2019893848437
Jan 2020806719506
Feb 2020819638422
Mar 2020960822412
Apr 2020568458372
May 2020575452507
Jun 2020536427566
Jul 2020570483379
Aug 2020569504274
Sep 2020781669192
Oct 2020744645187
Nov 2020635552195
Dec 2020656594179
Jan 2021742634464
Feb 2021867766649
Mar 20211041944785
Apr 2021960908647
May 2021869837560
Jun 2021483491153
Jul 2021499504129
Aug 2021511514129
Sep 2021528527169
Oct 2021598545169
Nov 2021609560170
Dec 2021614544168
Jan 2022529472154
Feb 2022559512152
Mar 2022859769171
Apr 2022787722217
May 2022651581155
Jun 2022548524138
Jul 2022519468185
Aug 2022625567162
Sep 2022651608154
Oct 2022658572164
Nov 2022539454141
Dec 2022475404108
Jan 2023488444130
Feb 2023513465130
Mar 2023697642182
Apr 2023594544150
May 2023675614169
Jun 2023538501110
Jul 2023617548143
Aug 2023532475123
Sep 2023553470183
Oct 2023571456150
Nov 2023482400192
Dec 2023508410172
Jan 2024237232150
Feb 2024461362162
Mar 2024659560162
Total652817684728664